Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
gene therapy
life sciences
national blog main
national top stories
new york blog main
san diego blog main
2
×
san francisco blog main
acadia pharmaceuticals
adverum biotechnologies
aimmune
alk
amgen
astellas pharma
atlas venture
audentes therapeutics
avalon ventures
aveo oncology
avidity biosciences
biogen
biotech
bluebird bio
boston
boston blog main
boston top stories
bristol-myers squibb
cerevel therapeutics
clinical data
drug pricing
drugs
duchenne muscular dystrophy
dyne therapeutics
egfr
facioscapulohumeral muscular dystrophy
glaxosmithkline
ifm therapeutics
jeff jonas
joi ito
joshua brumm
kaleido biosciences
What
data
2
×
drug
2
×
advanced
ago
arrival
award
bio
biotechs
cancer
considering
death
decades
dems
diseases
dyne
early
expected
experimental
eyes
genetic
given
having
humans
immunotherapy
ipo
ipos
long
longer
lung
medical
medicines
muscle
pricing
quick
rare
reach
roundup
sentence
thanks
that’s
Language
unset
2
×
Current search:
drug
×
unset
×
data
×
" san diego blog main "
×
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com
4 years ago
Bio Roundup: Award Winners, Lung Data, Dems on Drug Pricing & More
